Floatz logo

Therapeutic Asset Ratings

1,179 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Vistusertib
Endometrium Adenocarcinoma
M.D. Anderson Cancer CenterP1CC (43)
Vistusertib
Estrogen-Receptor Negative Breast Cancer
M.D. Anderson Cancer CenterP1CC (43)
Vistusertib
Her2-Receptor Negative Breast Cancer
M.D. Anderson Cancer CenterP1CC (43)
Vistusertib
Ovarian Serous Adenocarcinoma
M.D. Anderson Cancer CenterP1CC (43)
Vistusertib
Progesterone-Receptor Negative Breast Cancer
M.D. Anderson Cancer CenterP1CC (43)
Vistusertib
Breast Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Vistusertib
Uterine Corpus Endometrial Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Vistusertib
Uterine Corpus Cancer
M.D. Anderson Cancer CenterP1CC (43)
YTTRIUM (90 Y)
Metastatic Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
YTTRIUM (90 Y)
Liver Cancer
M.D. Anderson Cancer CenterP1CC (43)
Car.70/Il15-Transduced Cb-Nk Cells
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP1/2CC (43)
Car.70/Il15-Transduced Cb-Nk Cells
Plasma Cell Leukemia
M.D. Anderson Cancer CenterP1/2CC (43)
Cytokine-Treated Veto Cells
Myelodysplastic Syndrome
M.D. Anderson Cancer CenterP1/2CC (43)
Cytokine-Treated Veto Cells
Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP1/2CC (43)
FILGRASTIM-SNDZ
Lymphoblastic Lymphoma
M.D. Anderson Cancer CenterP1/2CC (43)
FILGRASTIM-SNDZ
T-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer CenterP1/2CC (43)
FILGRASTIM-SNDZ
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
M.D. Anderson Cancer CenterP1/2CC (43)
Girentuximab
Cancer
M.D. Anderson Cancer CenterP1/2CC (43)
GSK-2636771
Metastatic Melanoma
M.D. Anderson Cancer CenterP1/2CC (43)
HAFNIUM OXIDE
Metastatic Malignant Neoplasm
M.D. Anderson Cancer CenterP1/2CC (43)
Ivuxolimab
Castration-Resistant Prostate Carcinoma
M.D. Anderson Cancer CenterP1/2CC (43)
Ivuxolimab
Metastatic Malignant Neoplasm
M.D. Anderson Cancer CenterP1/2CC (43)
Ksq-001Ex
Lung Neoplasm
M.D. Anderson Cancer CenterP1/2CC (43)
Pelcitoclax
Acute Myeloid Leukemia
M.D. Anderson Cancer CenterP1/2CC (43)
Sabatolimab
Acute Myeloid Leukemia
M.D. Anderson Cancer CenterP2CC (42)
Showing 1001 to 1025 of 1,179 assets
PreviousPage 41 of 48Next